These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 37551556)
1. FOXO1-miR-506 axis promotes chemosensitivity to temozolomide and suppresses invasiveness in glioblastoma through a feedback loop of FOXO1/miR-506/ETS1/FOXO1. Chen C; Liu Y; Wang H; Zhang X; Shi Y; Chen J J Zhejiang Univ Sci B; 2023 Aug; 24(8):698-710. PubMed ID: 37551556 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA-128-3p Enhances the Chemosensitivity of Temozolomide in Glioblastoma by Targeting c-Met and EMT. Zhao C; Guo R; Guan F; Ma S; Li M; Wu J; Liu X; Li H; Yang B Sci Rep; 2020 Jun; 10(1):9471. PubMed ID: 32528036 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-640 Inhibition Enhances the Chemosensitivity of Human Glioblastoma Cells to Temozolomide by Targeting Bcl2 Modifying Factor. Jiang S; Luo C; Chen Y; Chen J; Tao S; Zou Q; He C; Dong S Biochem Genet; 2023 Apr; 61(2):538-550. PubMed ID: 35984538 [TBL] [Abstract][Full Text] [Related]
4. FOXO1 associated with sensitivity to chemotherapy drugs and glial-mesenchymal transition in glioma. Chen C; Han G; Li Y; Yue Z; Wang L; Liu J J Cell Biochem; 2019 Jan; 120(1):882-893. PubMed ID: 30216501 [TBL] [Abstract][Full Text] [Related]
5. RUNX1 (RUNX family transcription factor 1), a target of microRNA miR-128-3p, promotes temozolomide resistance in glioblastoma multiform by upregulating multidrug resistance-associated protein 1 (MRP1). Xu J; Song J; Xiao M; Wang C; Zhang Q; Yuan X; Tian S Bioengineered; 2021 Dec; 12(2):11768-11781. PubMed ID: 34895074 [TBL] [Abstract][Full Text] [Related]
6. miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2. Luo W; Yan D; Song Z; Zhu X; Liu X; Li X; Zhao S Life Sci; 2019 Jun; 226():98-106. PubMed ID: 30980849 [TBL] [Abstract][Full Text] [Related]
7. Micro-RNA29b enhances the sensitivity of glioblastoma multiforme cells to temozolomide by promoting autophagy. Xu JX; Yang Y; Zhang X; Luan XP Anat Rec (Hoboken); 2021 Feb; 304(2):342-352. PubMed ID: 32275350 [TBL] [Abstract][Full Text] [Related]
8. Exosomal transfer of miR-151a enhances chemosensitivity to temozolomide in drug-resistant glioblastoma. Zeng A; Wei Z; Yan W; Yin J; Huang X; Zhou X; Li R; Shen F; Wu W; Wang X; You Y Cancer Lett; 2018 Nov; 436():10-21. PubMed ID: 30102952 [TBL] [Abstract][Full Text] [Related]
9. Silencing lncRNA LINC01410 suppresses cell viability yet promotes apoptosis and sensitivity to temozolomide in glioblastoma cells by inactivating PTEN/AKT pathway via targeting miR-370-3p. Fu T; Yang Y; Mu Z; Sun R; Li X; Dong J Immunopharmacol Immunotoxicol; 2021 Dec; 43(6):680-692. PubMed ID: 34435542 [TBL] [Abstract][Full Text] [Related]
10. miR-20a mediates temozolomide-resistance in glioblastoma cells via negatively regulating LRIG1 expression. Wei J; Qi X; Zhan Q; Zhou D; Yan Q; Wang Y; Mo L; Wan Y; Xie D; Xie J; Yang S Biomed Pharmacother; 2015 Apr; 71():112-8. PubMed ID: 25960225 [TBL] [Abstract][Full Text] [Related]
11. Hsa_circ_0043949 reinforces temozolomide resistance via upregulating oncogene ITGA1 axis in glioblastoma. Li X; Wang N; Leng H; Yuan H; Xu L Metab Brain Dis; 2022 Dec; 37(8):2979-2993. PubMed ID: 36301458 [TBL] [Abstract][Full Text] [Related]
12. Extracellular vesicles carry miR-27a-3p to promote drug resistance of glioblastoma to temozolomide by targeting BTG2. Chen L; Li Z; Hu S; Deng Q; Hao P; Guo S Cancer Chemother Pharmacol; 2022 Feb; 89(2):217-229. PubMed ID: 35039898 [TBL] [Abstract][Full Text] [Related]
13. miR-519a enhances chemosensitivity and promotes autophagy in glioblastoma by targeting STAT3/Bcl2 signaling pathway. Li H; Chen L; Li JJ; Zhou Q; Huang A; Liu WW; Wang K; Gao L; Qi ST; Lu YT J Hematol Oncol; 2018 May; 11(1):70. PubMed ID: 29843746 [TBL] [Abstract][Full Text] [Related]
14. miR-140 targeting CTSB signaling suppresses the mesenchymal transition and enhances temozolomide cytotoxicity in glioblastoma multiforme. Ho KH; Cheng CH; Chou CM; Chen PH; Liu AJ; Lin CW; Shih CM; Chen KC Pharmacol Res; 2019 Sep; 147():104390. PubMed ID: 31398406 [TBL] [Abstract][Full Text] [Related]
15. Human bone marrow-derived mesenchymal stem cell-secreted exosomes overexpressing microRNA-34a ameliorate glioblastoma development via down-regulating MYCN. Wang B; Wu ZH; Lou PY; Chai C; Han SY; Ning JF; Li M Cell Oncol (Dordr); 2019 Dec; 42(6):783-799. PubMed ID: 31332647 [TBL] [Abstract][Full Text] [Related]
16. Exosomal transfer of miR-1238 contributes to temozolomide-resistance in glioblastoma. Yin J; Zeng A; Zhang Z; Shi Z; Yan W; You Y EBioMedicine; 2019 Apr; 42():238-251. PubMed ID: 30917935 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of microRNA-299-5p sensitizes glioblastoma cells to temozolomide via the MAPK/ERK signaling pathway. Peng Y; He X; Chen H; Duan H; Shao B; Yang F; Li H; Yang P; Zeng Y; Zheng J; Li Y; Hu J; Lin L; Teng L Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30061180 [TBL] [Abstract][Full Text] [Related]
18. Palmitic acid reduces the methylation of the FOXO1 promoter to suppress the development of diffuse large B-cell lymphoma via modulating the miR-429/DNMT3A axis. Li W; Gao M; Xue W; Li X; Chang Y; Zhang K; Wen C; Zhang M Chin J Nat Med; 2024 Jun; 22(6):554-567. PubMed ID: 38906602 [TBL] [Abstract][Full Text] [Related]
19. Hypoxia-mediated mitochondria apoptosis inhibition induces temozolomide treatment resistance through miR-26a/Bad/Bax axis. Ge X; Pan MH; Wang L; Li W; Jiang C; He J; Abouzid K; Liu LZ; Shi Z; Jiang BH Cell Death Dis; 2018 Nov; 9(11):1128. PubMed ID: 30425242 [TBL] [Abstract][Full Text] [Related]
20. Exosomal transfer of miR‑25‑3p promotes the proliferation and temozolomide resistance of glioblastoma cells by targeting FBXW7. Wang J; Li T; Wang B Int J Oncol; 2021 Aug; 59(2):. PubMed ID: 34278448 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]